Amphetamine discrimination as a test for anti-Parkinsonism drugs
- 1 July 1977
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 44 (1) , 51-56
- https://doi.org/10.1016/0014-2999(77)90115-7
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Turning in circles: The neuropharmacology of rotationLife Sciences, 1976
- Treatment of Parkinson's Disease with AporphinesNew England Journal of Medicine, 1976
- ?9-Tetrahydrocannabinol, ethanol, and amphetamine as discriminative stimuli-generalization tests with other drugsPsychopharmacology, 1976
- Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areasEuropean Journal of Pharmacology, 1975
- The discriminative control of operant behavior by intravenous administration of drugs in ratsPsychopharmacology, 1975
- Parkinson Disease Treated With a Suspected Dopamine Receptor AgonistArchives of Neurology, 1974
- ET495 and brain catecholamine mechanisms: Evidence for stimulation of dopamine receptorsEuropean Journal of Pharmacology, 1972
- Evidence for a new type of dopamine receptor stimulating agentJournal of Pharmacy and Pharmacology, 1971
- The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenatesJournal of Pharmacy and Pharmacology, 1970
- Mode of action of apomorphine and dexamphetamine on gnawing compulsion in ratsPsychopharmacology, 1967